AI channel feed – Endpoints News

AI channel feed

A Recursion veteran is mapping plant life to chart a course to new therapies — and investors like what they see

4 years ago

With a new $255M megaround in hand, Alex Zhavoronkov has big plans for Insilico. Are they feasible?

4 years ago

Exscientia spends SoftBank's cash in bid to edge out AI rivals

4 years ago

Flagship and Khosla Ventures team up for biotech's latest SPAC, with Valo Health winning a blank check ticket to Nasdaq

4 years ago

Tim Lu is ready to take his AI-focused biotech to the next level with first big fundraising round

4 years ago

Bristol Myers expands Celgene-era deal with Exscientia, taking its AI R&D engine to the next step

4 years ago

Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board

5 years ago

Andrew Radin orchestrates his AI discovery platform's pivot to R&D with a harmonious name change and eyes on the clinic

5 years ago

Fueled with a fresh half-billion dollars as AI investments boom, Exscientia is hitting the gas on drug development

5 years ago

Laying claim to another AI 'first,' Exscientia tees up an I/O drug for the clinic

5 years ago

With fresh investor cash in hand, Volastra partners with Microsoft to develop metastatic cancer biomarker platform

5 years ago

Betting early on an AI niche, RA Capital seeds a young founder's quest to unlock 'Holy Grail' targets

5 years ago

Exclusive: Microsoft, Sam Altman back a new AI biotech upstart

5 years ago

Daphne Koller lines up $400M for a global shopping spree to vault forward on AI drug discovery

5 years ago

BlackRock pushes Exscientia Series C to $100M as AI biotech boom continues

5 years ago

Insilico preps first candidate for IND studies, hoping to launch trial in IPF by end of 2021

5 years ago

Wading deeper into target discovery and validation, Immunai bags $60M to beef up both AI algorithms and lab benches

5 years ago

Dyno sketches tens of thousands of viable next-gen AAV capsids with the help of machine learning — paper

5 years ago

On the hunt for a better antibody, BigHat Biosciences debuts with $19M Series A to scale its 'wet lab' AI platform

5 years ago

Roche and Genentech's latest AI collaborator raises $25M Series A to reinvent one of the oldest cancer targets

5 years ago

AstraZeneca scores new goal on the pipeline front, adding its first AI-generated target to the portfolio

5 years ago

On a mission to 'unify' drug discovery and cell-line development, AbSci acquires AI outfit Denovium

5 years ago

Looking to solve public health crises through discovery, Gates Foundation taps AI firm Exscientia to look for answers

5 years ago

Pear Therapeutics nabs $80M Series D to commercialize three digital therapeutics

5 years ago

First page Previous page 8 9 101112 13 14 Next page Last page